The product developed by MRIguidance, BoneMRI, is a software solution that enables unprecedented 3D visualisation of the bone anatomy with conventional MRI scanners. Until today MRI scanners were mainly used to assess soft tissues. BoneMRI allows for a one-stop-shop in medical imaging; one exam to visualize all human tissues and without making use of harmful radiation.
Stokhos designs and builds software delivering real-time advice that optimises emergency vehicle coverage and reduces response times. This innovative software, called "Seconds", was developed in tandem with an emergency region in the Netherlands. This region achieved better response times using Seconds. This investment is utilised to further improve the product and facilitate (inter)national roll out.
Aidence improves healthcare using computer-aided diagnostics, with an initial application for lung cancer detection. Aidence’s software provides faster, cheaper and more accurate diagnoses of X-ray, MRI and CT images. The core technology is deep learning, a revolutionary type of artificial intelligence that allows image recognition at a human level.
ANW Nederland organises medical accessibility services for long-term care. ANW Nederland provides an affordable and reliable service to healthcare institutions using triage, scheduling and good ICT support. As a result, the expertise of the specialised physicians is available where it is most useful, namely during the day with clients in the healthcare institution.
ViCentra developed a small insulin pump that offers the diabetic patient as much freedom of movement as possible and that can accurately manage his/her glucose level. By cleverly developing the pump with new technologies, ViCentra can keep costs low and thus make the pump available to a large group.
Livassured has developed the NightWatch in collaboration with institutions for epilepsy care. This is a monitoring device for epilepsy patients to indicate nightly attacks with more certainty. The device uses motion and heart rate sensors and can provide an early indication of an epileptic attack based on a tested algorithm.
Pulsecath develops and sells an external heart pump. It is inserted pre-op and can remain in place for a few days after surgery. The Pulsecath is used during cardiac surgery and offers major advantages over existing heart pumps.
Cloud9 Software delivers software (research manager) to healthcare organisations and commercial research institutions that support clinical research. Cloud9 Software also has a solution for registering, collecting, validating and reporting data on the quality of care within hospitals.
Prolira develops a medical device to detect delirium with a three-point EEG measurement. The company is a spin-off of the University Medical Centre Utrecht. Delirium is common in hospital patients, with often severe consequences.
Stroke2prevent markets the A-view, a medical device developed to combat strokes due to cardiac surgery and cardiological aortic valve replacement. The A-view can reveal arteriosclerosis in the aorta so that the medical team can use this information to determine the correct operating strategy.
Fabpulous provides a test that can establish the presence of tissue damage in the heart within three minutes using two drops of blood taken by a finger prick. As a result, it can be determined in the first line whether someone has had a heart attack.
Gannet makes an innovative surgical implant designed for setting femoral neck fractures (medial column fractures). What makes this implant unique is the rotational stability combined with a low implant volume. The implant allows the patient to walk again quite quickly. Using the Gannet helps to reduce the number of complications and reoperations, which is good for the patient and reduces healthcare costs.
SwyMed facilitates remote working in healthcare with video links coupled to diagnostic equipment, hospital information systems and media storage, such as x-rays. This also works when mobile and under all circumstances, e.g. for sharing video and measurement data from an ambulance with a specialist in a hospital. The swyMed platform supports telephones, computers and tablets.
Noviosense develops a sensor that can measure glucose in the eye. The sensor measures glucose concentrations in the eye fluid and sends a message to a device or mobile phone. Type 1 diabetes patients can use this system for continuous glucose measurement as an alternative to the current method of taking a blood sample.